Adams S, Othus M, Patel SP, Miller KD, et al. A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clin Cancer Res 2021 Oct 29. pii: 1078-0432.CCR-21-2182.
PMID: 34716198